Covid-19: 100% Himachal Pradesh adults given first dose
India | Aug 30, 2021, 08:48 AM ISTHimachal Pradesh became the first state in the country to complete administering the first dose of COVID-19 vaccine for the 18-plus age group.
Himachal Pradesh became the first state in the country to complete administering the first dose of COVID-19 vaccine for the 18-plus age group.
Tehran police chief Hossein Rahimi said robbers attacked and seized 300 vaccines after a courier service left a Health Ministry medical storage facility south of the capital.
The trial would be held across 10 sites and would cover 920 children -- 460 each in the age groups of 12-17 and 2-11 -- according to official sources.
According to the 7 pm provisional report, more than 65 lakh doses were administered on Saturday.
Taking to Twitter, Prime Minister Narendra Modi said, "record vaccination numbers today! Crossing 1 crore is a momentous feat. Kudos to those getting vaccinated and those making the vaccination drive a success."
Basavaraja Bommai on Thursday said that the Centre has agreed to increase the monthly supply of COVID-19 vaccines to Karnataka.
An expert panel set up by an institute under the Ministry of Home Affairs (MHA) has predicted that the third wave of COVID-19 can hit the country anytime between September and October and suggested significantly ramping up the vaccination pace.
Pfizer’s vaccine — along with those from Moderna and Johnson & Johnson — still underwent testing in tens of thousands of people to establish safety and effectiveness against COVID-19.
According to the 7 pm provisional report, 56,10,116 vaccine doses have been administered on Monday, the ministry said.
The government aims to administer one crore doses per day, and its expected vaccine availability between August and December is about 135 crore doses.
Maharashtra Public Health Minister Rajesh Tope said the state government was insisting on supplying higher number of vials for a long time so that we can "increase the pace of immunisation against COVID-19".
The company's indigenously developed needle-free three-dose COVID-19 vaccine ZyCoV-D was granted emergency use authorisation (EUA) by the drug regulator on Friday, making it the first vaccine to be administered to beneficiaries in the age group of 12-18 years in the country.
Zydus Group MD Dr. Sharvil Patel has claimed that 'ZyCoV-D' vaccine holds about 66% efficacy against the Delta variant of COVID-19.
The single-shot vaccine of J&J is the second Covid-19 vaccine which has already been approved for the Emergency Use Authorisation (EUA) through the fast-track approval route by the Drug Controller General of India.
Union Health Minister Mansukh Mandaviya on Thursday said that the results of an ongoing research for development of Covid-19 vaccines for children may arrive next month and the antidote may be launched "very soon".
Over 3.86 crore people did not get their second dose of anti-Covid vaccines -- Covishield and Covaxin -- within the stipulated period of time, the government has said in response to an RTI query.
The researchers, however, noted that with Delta, Pfizer-BioNTech vaccine and Oxford-AstraZeneca preventive, known as Covishield in India, still offer good protection against new infections.
Union Health Minister Mansukh Mandaviya had told BJP MPs that Covid vaccination for children is likely to start soon.
The doses were seized by authorities in India and Africa between July and August, a WHO statement said. It also said the vaccine's maker, the Serum Institute of India, confirmed that the doses were fake.
The study found that the delta variant of covid was unable to evade all but one of the antibodies the researchers tested. Other variants of concern, such as beta, avoided recognition and neutralization by several of the antibodies.
Top News
Latest News